Kratom and 7-OH products are available in many smoke shops. But earlier this year, the FDA recommended certain 7-OH products be scheduled alongside opioids. This isn’t the first time kratom has come under scrutiny. Nearly a decade ago, the DEA wanted to make certain active ingredients in kratom controlled substances. Meaning products would go from being widely available to highly restricted. After a massive wave of protest, the DEA decided not to move forward. Producer <a href="https://www.npr.org/people/1112796909/rachel-carlson"target="_blank" >Rachel Carlson</a> joins host <a href="https://www.npr.org/people/767284140/emily-kwong"target="_blank" >Emily Kwong</a> to talk about what could happen this time around, and what scientists know – and don’t know – about kratom and 7-OH.  Interested in more of the science behind drugs and supplements? Email us your question at <a href="mailto:shortwave@npr.org"target="_blank" >shortwave@npr.org</a>. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at <a href="http://plus.npr.org/shortwave"target="_blank" >plus.npr.org/shortwave</a>. Learn more about sponsor message choices: <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a> <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Why Kratom Is At The Heart Of A Big Public Health Debate

Short Wave

AI Chapters

AI Insights

Reviews